Key Insights

Highlights

Success Rate

97% trial completion (above average)

Published Results

39 trials with published results (21%)

Research Maturity

135 completed trials (74% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.2%

4 terminated out of 183 trials

Success Rate

97.1%

+10.6% vs benchmark

Late-Stage Pipeline

21%

39 trials in Phase 3/4

Results Transparency

29%

39 of 135 completed with results

Key Signals

39 with results97% success

Data Visualizations

Phase Distribution

137Total
Not Applicable (62)
P 1 (17)
P 2 (19)
P 3 (16)
P 4 (23)

Trial Status

Completed135
Unknown21
Recruiting10
Withdrawn6
Terminated4
Active Not Recruiting2

Trial Success Rate

97.1%

Benchmark: 86.5%

Based on 135 completed trials

Clinical Trials (183)

Showing 20 of 20 trials
NCT03670316Phase 4Completed

Effectiveness of a Smoking Cessation Algorithm Integrated Into HIV Primary Care

NCT06585631Not ApplicableRecruiting

The Collaborative Care PrTNER Study

NCT07501624Not ApplicableEnrolling By Invitation

Engaging Pharmacists to Advance Tobacco Treatment Service Delivery

NCT06282328Completed

HIV HOspital TEsting: Bringing the Hidden to Light in the Hospital Setting

NCT05373758Not ApplicableRecruiting

A Randomized Clinical Trial to Evaluate Solutions for the Management of Virologic Failure on TLD in Sub-Saharan Africa

NCT05390424Not ApplicableRecruiting

Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot

NCT01206920Recruiting

The DC Cohort Longitudinal HIV Status Neutral Study

NCT04770701Phase 4Completed

Protect and Improve Cluster of Differentiation 4 (CD4) Cells and B Cells Lymphocytes

NCT03633721Phase 2Completed

Acute Effects of Cannabis on Cognition and Mobility in Older HIV-infected and HIV-Un-infected Women

NCT07131826Not Yet Recruiting

The Quality of Life and Viral Control Effect of AIDS Patients After Long-acting Injection of Cabotegravir and Rilpivirine

NCT06913660Not ApplicableActive Not Recruiting

ALHIV Smartphone Game Study

NCT05939167Phase 1RecruitingPrimary

Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage

NCT02284035Phase 3CompletedPrimary

Safety & Efficacy of Dual Therapy With Raltegravir/Lamivudine

NCT07032363Not ApplicableSuspended

Implementing Depression and Adherence Treatment

NCT05421286Active Not Recruiting

The MISTRAL Study: Gut Microbiome Correlates of Serious AIDS and Non-AIDS Events

NCT06045923Recruiting

Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV

NCT04059770Phase 2Completed

Randomized Trial of Liposomal Amphotericin B for Histoplasmosis in AIDS Patients

NCT06202898Not ApplicableRecruiting

Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)

NCT04896216Not ApplicableCompleted

Standardized Patients to Measure and Address Intersectional Stigma

NCT02029430Phase 2Completed

A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma

Scroll to load more

Research Network

Activity Timeline